LINEZOLID SZ linezolid 600 mg/300 mL injection IV infusion bag

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

linezolid, Quantity: 2 mg/mL

Available from:

Sandoz Pty Ltd

INN (International Name):

Linezolid

Pharmaceutical form:

Injection, intravenous infusion

Composition:

Excipient Ingredients: citric acid; sodium hydroxide; sodium citrate dihydrate; water for injections; hydrochloric acid; glucose monohydrate

Administration route:

Intravenous, Intravenous Infusion

Units in package:

5 bags, 10 bags, 1 bag

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Linezolid SZ is indicated for the treatment of suspected or proven infections due to Gram positive organisms resistant to multiple classes of antibiotics,including methicillin resistant Staphylococcus species and vancomycin resistant Enterococcus species. Linezolid is active against Gram-positive bacteria only. Linezolid has no clinical activity against Gram-negative pathogens. Specific Gram-negative therapy is required if a concomitant Gram-negative pathogen is documented or suspected

Product summary:

Visual Identification: Clear, colourless or yellowish solution, practically free from particles, in a clear, colourless or yellowish infusion bag with one port or two ports in a transparent overwrap bag; Container Type: Bag; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Restricted flow insert

Authorization status:

Licence status A

Authorization date:

2017-01-04